Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;21(1):9-13.
doi: 10.17925/EE.2025.21.1.7. Epub 2025 Apr 28.

The Role of Remote Glucose Management Using Real-time Continuous Glucose Monitoring Systems in ICU-hospitalized Patients with COVID-19

Georgios Logothetis  1 , Konstantinos Avramidis  2 , Evanthia Konstantaki  1 , Vasiliki Matziou  1 , John Doupis  3
Affiliations
Review

The Role of Remote Glucose Management Using Real-time Continuous Glucose Monitoring Systems in ICU-hospitalized Patients with COVID-19

Georgios Logothetis et al. touchREV Endocrinol. 2025 May.

Abstract

The recent coronavirus disease 2019 (COVID-19) pandemic has induced many challenges in the clinical environment worldwide. In a bid to reduce the exposure of healthcare providers to severe acute respiratory syndrome coronavirus 2 and the utilization of personal protective equipment (PPE), while maintaining optimal patient care, in April 2020, the US Food and Drug Administration issued a new policy, allowing the use of continuous glucose monitoring (CGM) systems in the intensive care unit (ICU) setting. This article aimed to explore the role of real-time continuous glucose monitoring systems in patients in the ICU with COVID-19. The hybrid protocols integrating real-time CGM and point of care seem to be a feasible and safe alternative for the glycaemic management of critically ill patients with COVID-1 9, including the reduction of healthcare providers' exposure and the preservation of PPE, whilst achieving and maintaining optimal glycaemic control.

Keywords: Accuracy; COVID-19; clinical benefits; continuous glucose monitoring systems; critically ill patients; glycaemic management; intensive care units.

PubMed Disclaimer

Conflict of interest statement

Disclosures: John Doupis has received honoraria for lectures and consultation fees from Abbott. Georgios Logothetis, Konstantinos Avramidis, Evanthia Konstantaki and Vasiliki Matziou have no financial or non-financial relationships or activities to declare in relation to this article.

References

    1. Cascella M, Rajnik M, Aleem A . StatPearls. Treasure Island, FL: StatPearls Publishing; 2022. Features, evaluation, and treatment of coronavirus (COVID-19) - PubMed
    1. Richardson S, Hirsch JS, Narasimhan M et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020;323:2052–9. doi: 10.1001/jama.2020.6775. - DOI - PMC - PubMed
    1. Kumar A, Arora A, Sharma P et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A metaanalysis. Diabetes Metab Syndr. 2020;14:535–45. doi: 10.1016/j.dsx.2020.04.044. - DOI - PMC - PubMed
    1. Guo W, Li M, Dong Y et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36:e3319. doi: 10.1002/dmrr.3319. - DOI - PMC - PubMed
    1. Fadini GP, Morieri ML, Longato E et al. Prevalence and impact of diabetes among people infected with SARS- CoV-2. J Endocrinol Invest. 2020;43:867–9. doi: 10.1007/s40618-020-01236-2. - DOI - PMC - PubMed

LinkOut - more resources